Hikal informs about transcript of the earnings call

16 Nov 2022 Evaluate

In continuation of its letters dated November 08, 2022 and November 09, 2022 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hikal has informed that it enclosed the transcript of the earnings call held on November 9, 2022.

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

401.10 -15.45 (-3.71%)
25-Apr-2025 12:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1778.85
Dr. Reddys Lab 1168.00
Cipla 1522.45
Lupin 2048.40
Zydus Lifesciences 866.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...